Nishihara T - Search Results

1

Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.

Tamamori Y, Sawada T, Nishihara T, Yamashita Y, Ohira M, Ho JJ, Kim YS, Hirakawa-Y S Chung K. Tamamori Y, et al. Among authors: nishihara t. Int J Oncol. 2002 Sep;21(3):649-54. Int J Oncol. 2002. PMID: 12168113

2

A role for protease-activated receptor-2 in pancreatic cancer cell proliferation.

Shimamoto R, Sawada T, Uchima Y, Inoue M, Kimura K, Yamashita Y, Yamada N, Nishihara T, Ohira M, Hirakawa K. Shimamoto R, et al. Among authors: nishihara t. Int J Oncol. 2004 Jun;24(6):1401-6. Int J Oncol. 2004. PMID: 15138580

3

Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.

Inoue M, Sawada T, Uchima Y, Kimura K, Nishihara T, Tanaka H, Yashiro M, Yamada N, Ohira M, Hirakawa K. Inoue M, et al. Among authors: nishihara t. Oncol Rep. 2005 Dec;14(6):1445-51. Oncol Rep. 2005. PMID: 16273237

4

Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine.

Kimura K, Sawada T, Komatsu M, Inoue M, Muguruma K, Nishihara T, Yamashita Y, Yamada N, Ohira M, Hirakawa K. Kimura K, et al. Among authors: nishihara t. Clin Cancer Res. 2006 Aug 15;12(16):4925-32. doi: 10.1158/1078-0432.CCR-06-0544. Clin Cancer Res. 2006. PMID: 16914581

5

Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.

Yamamoto A, Sawada T, Yamashita Y, Nishihara T, Ho JJ, Kim Y, Chung KH. Yamamoto A, et al. Among authors: nishihara t. Oncol Rep. 1999 Jan-Feb;6(1):179-84. doi: 10.3892/or.6.1.179. Oncol Rep. 1999. PMID: 9864424

6

Antibody-dependent cytotoxicity mediated by chimeric monoclonal antibody Nd2 and experimental immunotherapy for pancreatic cancer.

Nishihara T, Sawada T, Yamamoto A, Yamashita Y, Ho JJ, Kim YS, Chung KH. Nishihara T, et al. Jpn J Cancer Res. 2000 Aug;91(8):817-24. doi: 10.1111/j.1349-7006.2000.tb01019.x. Jpn J Cancer Res. 2000. PMID: 10965023 Free PMC article.

7

Identification of a trypsinogen activity stimulating factor produced by pancreatic cancer cells: its role in tumor invasion and metastasis.

Uchima Y, Sawada T, Nishihara T, Umekawa T, Ohira M, Ishikawa T, Nishino H, Hirakawa K. Uchima Y, et al. Among authors: nishihara t. Int J Mol Med. 2003 Dec;12(6):871-8. Int J Mol Med. 2003. PMID: 14612960

8

Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.

Uchima Y, Sawada T, Nishihara T, Maeda K, Ohira M, Hirakawa K. Uchima Y, et al. Among authors: nishihara t. Pancreas. 2004 Aug;29(2):123-31. doi: 10.1097/00006676-200408000-00007. Pancreas. 2004. PMID: 15257104

9

Preoperative clinical radioimmunodetection of pancreatic cancer by 111 In-labeled chimeric monoclonal antibody Nd2.

Sawada T, Nishihara T, Yamamoto A, Teraoka H, Yamashita Y, Okamura T, Ochi H, Ho JJ, Kim YS, Hirakawa K. Sawada T, et al. Among authors: nishihara t. Jpn J Cancer Res. 1999 Oct;90(10):1179-86. doi: 10.1111/j.1349-7006.1999.tb00693.x. Jpn J Cancer Res. 1999. PMID: 10595748 Free PMC article.

10

Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer.

Teraoka H, Sawada T, Nishihara T, Yashiro M, Ohira M, Ishikawa T, Nishino H, Hirakawa K. Teraoka H, et al. Among authors: nishihara t. Br J Cancer. 2001 Aug 17;85(4):612-7. doi: 10.1054/bjoc.2001.1941. Br J Cancer. 2001. PMID: 11506504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

755 results

Search Page

Filters